Abstract:Naturally occurring stilbenoids, such as the (E)-stilbenoid resveratrol and the (Z)-stilbenoid combretastatin A4, have been considered as promising lead compounds for the development of anticancer drugs. The antitumour properties of stilbenoids are known to be modulated by cytochrome P450 enzymes CYP1A1 and CYP1B1, which contribute to extrahepatic phase I xenobiotic and drug metabolism. Thirty-four methyl ether analogues of resveratrol were synthesised, and their anticancer properties were assessed, using the MTT cell proliferation assay on a panel of human breast cell lines. Breast tumour cell lines that express CYP1 were significantly more strongly affected by the resveratrol analogues than the cell lines that did not have CYP1 activity. Metabolism studies using isolated CYP1 enzymes provided further evidence that (E)-stilbenoids can be substrates for these enzymes. Structures of metabolic products were confirmed by comparison with synthetic standards and LC-MS co-elution studies. The most promising stilbenoid was (E)-4,3′,4′,5′-tetramethoxystilbene (DMU212). The compound itself showed low to moderate cytotoxicity, but upon CYP1-catalysed dealkylation, some highly cytotoxic metabolites were formed. Thus, DMU212 selectively affects proliferation of cells that express CYP1 enzymes.

What problem does this paper attempt to address?

This paper aims to solve the problem of how to improve the anti - cancer effect by designing synthetic methoxylated resveratrol analogues as potential prodrugs. Specifically, the researchers synthesized 34 methoxylated resveratrol analogues and evaluated their anti - cancer activities in breast cancer cell lines expressing CYP1 enzymes (especially CYP1A1 and CYP1B1). These enzymes are widely present in extracellular liver tissues, can metabolize drugs and xenobiotics, and play an important role in the processes of drug bio - activation and detoxification. ### Research Background - **Natural Products and Anti - cancer Drugs**: Natural products, especially plant - derived compounds, have always been an important source for the development of anti - cancer drugs. For example, compounds with stilbene structures have attracted wide attention due to their significant anti - cancer properties. - **Resveratrol and Its Analogues**: Resveratrol is a naturally occurring stilbene compound, which exists in red wine, grape skins, peanuts and cranberries, and has attracted much attention because of its potential anti - cancer effects. However, resveratrol has poor pharmacokinetic properties and is easily and rapidly metabolized into its main phase II metabolites, such as sulfates and glucuronides, and then excreted from the body. - **The Role of CYP1 Enzymes**: CYP1A1 and CYP1B1 are part of the cytochrome P450 superfamily and are mainly involved in the bio - activation and detoxification of xenobiotics and endogenous substrates. These enzymes are expressed in multiple tissues, and especially in tumor tissues, the expression level of CYP1B1 is relatively high. ### Research Purposes - **Design of Prodrugs**: The researchers designed a series of methoxylated analogues of resveratrol, hoping that these compounds could be selectively activated under the action of CYP1 enzymes to form metabolites with tyrosine kinase inhibitor or anti - mitotic activities. - **Evaluation of Anti - cancer Activity**: The anti - cancer activities of these synthetic analogues in different breast cancer cell lines, especially those expressing CYP1 enzymes, were evaluated by MTT cell proliferation assays. ### Key Findings - **High Selectivity of DMU212**: Among them, (E)-4,3′,4′,5′-tetramethoxystilbene (DMU212) showed the highest selectivity. In the normal cell line MCF10A that does not express CYP1 enzymes, the cytotoxicity of DMU212 was low; while in the tumor cell line MDA - MB - 468 that expresses CYP1 enzymes, the cytotoxicity of DMU212 was significantly enhanced, with an IC50 value of only 10 nM, showing extremely high tumor selectivity (TS value of 4300). - **Activity of Metabolites**: Further metabolic studies showed that DMU212 was dealkylated under the action of CYP1 enzymes to form highly cytotoxic metabolites, such as DMU214 and DMU283, and these metabolites showed high toxicity to all tested cell lines. ### Conclusion This study successfully designed and synthesized resveratrol analogues with high selectivity and high anti - cancer activity, especially DMU212, which provides new ideas for the development of new anti - cancer drugs. By selectively activating CYP1 enzymes, these compounds are expected to be used clinically to treat tumors expressing CYP1 enzymes.

CYP1-Activation and Anticancer Properties of Synthetic Methoxylated Resveratrol Analogues

Synthesis and Estrogen-Like Activity of Resveratrol Analogues

Cytotoxicity of Benzofuran-Containing Simplified Viniferin Analogues

Synthesis and mechanistic studies of novel spin-labeled combretastatin derivatives as potential antineoplastic agents.

Design, Synthesis and Biological Evaluation of a Series of New Resveratrol Analogues As Potential Anti-Cancer Agents

Synthesis and anticancer activity of novel coumarin-stilbene hybrids with different hydrocarbon chains as linkers

Synthesis and Cytotoxic Evaluation of A Series of Resveratrol Derivatives Modified in C2 Position

Pterostilbene Simultaneously Induces Apoptosis, Cell Cycle Arrest and Cyto-Protective Autophagy in Breast Cancer Cells.

Synthesis and Biological Evaluation of Resveratrol Methoxy Derivatives

Synthesis and cytotoxic evaluation of a series of resveratrol derivatives.

Antitumor Effects of Naturally Occurring Oligomeric Resveratrol Derivatives

Synthesis of Alpha-Aminoalkyl Phosphonate Derivatives of Resveratrol As Potential Antitumour Agents

Synthesis Of Resveratrol Analogues, And Evaluation Of Their Cytotoxic And Xanthine Oxidase Inhibitory Activities

Coumarins derived from natural methoxystilbene as oxidative stress-related disease alleviators: Synthesis and in vitro - in silico study

Chemoenzymatic Synthesis of Original Stilbene Dimers Possessing Wnt Inhibition Activity in Triple-Negative Breast Cancer Cells Using the Enzymatic Secretome of Botrytis cinerea Pers.

Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) by resveratrol derivatives in cancer therapy: in silico approach

Synthesis and biological evaluation of novel demethylzeylasteral derivatives as potential anticancer agents

Cytotoxic, Antiangiogenic and Antitelomerase Activity of Glucosyl- and Acyl- Resveratrol Prodrugs and Resveratrol Sulfate Metabolites

Synthesis of Rseveratrol Analogues

Main Determinants Affecting the Antiproliferative Activity of Stilbenes and Their Gut Microbiota Metabolites in Colon Cancer Cells: A Structure-Activity Relationship Study

Growth-Inhibiting Activity of Resveratrol Imine Analogs on Tumor Cells in Vitro